Iris Dotan, MD is the director of the division of Gastroenterology at the Rabin Medical Center, Petah Tikva, Israel and is affiliated with the Sackler Faculty of Medicine, Tel Aviv, Israel.
Professor Dotan received her medical degree from the Sackler Faculty of Medicine and her postdoctoral fellowship was at the Immunobiology Center, Mount Sinai Medical Center, in New York, NY, where she focused on intestinal epithelial cell biology. She is board certified in internal medicine and in gastroenterology and liver diseases. Professor Dotan’s clinical and research interests focus on biomarker-based stratification of patients with inflammatory bowel diseases and a personalized approach to their treatment and care, biologicals, and novel therapies for inflammatory bowel disease. She also has interests in the follow-up of patients with ulcerative colitis before and after restorative proctocolectomy (pouch surgery), in a comprehensive, multidisciplinary pouch clinic.
She conducts translational research in mucosal immunology, focusing on the interactions of intestinal epithelial cells and mucosal lymphocytes with their environment. She first described the anti-glycan antibodies and their relevance to Crohn's disease and investigates the role of glycans in intestinal immune responses. Professor Dotan has published more than 150 papers in peer-reviewed journals. She is the past president of the Israeli Association of Gastroenterology and Liver Diseases, a member of ECCO, the IOIBD Vice Chair, the Scientific Committee of UEG, and the Immunology and IBD Section of the AGA.